CEPEPRUBART
UNII FR57BKG0QJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Cepeprubart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FR57BKG0QJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2769758-59-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

FR57BKG0QJ

CAS Registry Number

2769758-59-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CEPEPRUBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C203154

National Cancer Institute reference terminology for clinical and research data.

INN ID

12715

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cepeprubart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CEPEPRUBART

Common Names & Synonyms

ANTI-PSGL-1 ANTIBODY SELK2

CEPEPRUBART [INN]

CEPEPRUBART [WHO-DD]

GAMMA2 HEAVY CHAIN (1-439) (VH (HOMO SAPIENS IGHV3-30*03(91.8%) -(IGHD) -IGHJ5*02 (100%) , CDR-IMGT (8.8.6) (26-33.51-58.97-102)) (1-113) -HOMO SAPIENS IGHG2*02, G2M23 CH2 M45.1, A105 (CH1 (114-211), HINGE 1-12 (212-223), CH2 M45.1 (274),K105>A (314) (224-332), CH3 (333-437), CHS (438-439)) (114-439)), (127-219')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-219') (V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV1-110*01 (90.0%) -IGKJ2*03 (81.8%), S120>Q (105'), K123>R (108')/HOMO SAPIENS IGKV2D-29*02 (86.0%) -IGKJ5*01 (91.7%) CDR-IMGT (11.3.9) (27'-37'.55'-57'.94'-102')) (1'-112') -HOMO SAPIENS IGKC*01 (100%), KM3, A45.1(158'), V101 (196') (113'-219')); DIMER (215-215'':216-216'':219-219'':222-222'')-TETRAKISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-S, GLYCOFORM ALFA

IMMUNOGLOBULIN G2, ANTI-(HUMAN CD162 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL SELK2 .GAMMA.2-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SELK2 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G2-KAPPA, ANTI-(HOMO SAPIENS SELPLG (SELECTIN P LIGAND, PSGL-1, P-SELECTIN GLYCOPROTEIN LIGAND 1, CD162)), MONOCLONAL ANTIBODY

SELK2

External Clinical & Regulatory Resources

Previous UNIIFR5546FG9U

Next UNIIFR5B7CU4CF